|
Abbott Laboratories (ABT) |
|
Abbott Laboratories's Comment on Competitors and Industry Peers
Abbott's products face intense competition from its competitors' products. Competitors'
products may be safer, more effective, more effectively marketed or sold, or have
lower prices or superior performance features than Abbott's products.
Overall company Market Share Q4 2020 |
Due to strong revenue growth of 28.71 % in Overall company Abbott Laboratories improved its market share, to approximate 5.8 %.
<< More on ABT Market Share.
|
|
|
*Market share calculated with total revenue.
ABT's vs. Competition, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
COMPANY NAME |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
Abbott Laboratories |
34,608 |
220,369 |
4,495 |
77,000 |
Actavis Plc |
10,573 |
4,714 |
-751 |
19,200 |
Bristol Myers Squibb Co |
42,518 |
151,779 |
-8,995 |
25,000 |
Cephalon, Inc. |
0 |
0 |
0 |
0 |
Johnson and Johnson |
82,584 |
432,282 |
14,714 |
126,500 |
Eli Lilly And Company |
24,540 |
170,627 |
6,194 |
39,135 |
Merck and Co Inc |
47,994 |
195,825 |
7,082 |
70,000 |
Mylan N v |
16,861 |
8,208 |
266 |
25,000 |
Pfizer Inc |
41,908 |
212,290 |
9,652 |
78,300 |
Watson Pharmaceuticals Inc |
0 |
0 |
0 |
0 |
Wyeth |
0 |
0 |
0 |
0 |
Abbvie inc |
45,804 |
190,487 |
4,622 |
26,000 |
Amgen Inc |
32,341 |
149,602 |
7,264 |
17,900 |
Biogen Inc |
13,445 |
41,548 |
4,061 |
7,550 |
Celgene Corp |
16,982 |
78,961 |
1,834 |
6,012 |
Gilead Sciences Inc |
24,689 |
83,657 |
89 |
7,000 |
Hospira Inc |
6,921 |
0 |
-8 |
0 |
SCHERING-PLOUGH CORPORATION |
0 |
0 |
0 |
0 |
Bard C R Inc |
5,308 |
28,675 |
690 |
13,900 |
Becton Dickinson And Company |
18,207 |
74,697 |
1,600 |
30,619 |
Covidien Plc |
10,880 |
0 |
1,605 |
39,500 |
Danaher Corporation |
22,284 |
174,834 |
3,646 |
71,000 |
Helen Of Troy Limited |
2,032 |
5,522 |
229 |
1,610 |
Honeywell International Inc |
32,637 |
163,634 |
4,865 |
131,000 |
Atyr Pharma Inc |
10 |
42 |
-16 |
0 |
3m Company |
32,184 |
114,881 |
5,388 |
89,800 |
Sigma Aldrich Corp |
4,724 |
0 |
491 |
9,300 |
Thermo Fisher Scientific Inc |
32,218 |
198,025 |
6,375 |
51,000 |
Balchem Corporation |
704 |
3,973 |
85 |
1,060 |
Dupont De Nemours Inc |
20,397 |
56,256 |
-2,923 |
63,000 |
Fmc Corporation |
4,642 |
14,700 |
551 |
5,900 |
Zivo Bioscience Inc |
0 |
50 |
-9 |
2 |
Boston Scientific Corporation |
9,913 |
57,746 |
-82 |
24,000 |
Edwards Lifesciences Corporation |
4,386 |
91,822 |
823 |
0 |
Medtronic Plc |
27,926 |
169,731 |
2,903 |
49,000 |
St Jude Medical Inc |
8,242 |
0 |
692 |
16,000 |
Synutra International, Inc. |
345 |
0 |
24 |
2,600 |
SUBTOTAL |
678,807 |
3,094,936 |
77,454 |
1,123,888 |
|